RI
RTW Investments Portfolio holdings
AUM
$7.02B
1-Year Return
28.16%
This Quarter Return
-25.07%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.09B
AUM Growth
-$581M
(-35%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-10.07%
Top 10 Holdings %
Top 10 Hldgs %
62.57%
Holding
59
New
13
Increased
22
Reduced
10
Closed
12
Top Buys
| 1 |
Q32 Bio
QTTB
|
$26.8M |
| 2 |
Adverum Biotechnologies
ADVM
|
$19.1M |
| 3 |
SI-BONE Inc
SIBN
|
$16.8M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$16.6M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$15.9M |
Top Sells
| 1 |
ProQR Therapeutics
PRQR
|
$51.9M |
| 2 |
PTC Therapeutics
PTCT
|
$46.4M |
| 3 |
CORI
Corium International, Inc.
CORI
|
$34.3M |
| 4 |
Illumina
ILMN
|
$30.3M |
| 5 |
Qiagen
QGEN
|
$29.4M |
Sector Composition
| 1 | Healthcare | 91.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
uniQure
QURE
$973M
| $13.3M | 1.22% |
461,837
+32,857
| +8% | +$947K |
|
27
Johnson & Johnson
JNJ
$431B
| $10.4M | 0.95% |
+80,583
| New | +$10.4M |
|
|
CNCE
28
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $9.9M | 0.91% |
+788,877
| New | +$9.9M |
|
|
VRAY
29
DELISTED
ViewRay, Inc.
VRAY
| $8.28M | 0.76% |
1,364,156
-2,025,342
| -60% | -$12.3M |
|
30
CareDx
CDNA
$697M
| $8.24M | 0.76% |
327,703
-30,063
| -8% | -$756K |
|
31
OrthoPediatrics
KIDS
$519M
| $7.85M | 0.72% |
+225,000
| New | +$7.85M |
|
32
Standard BioTools
LAB
$493M
| $7.62M | 0.7% |
+884,235
| New | +$7.62M |
|
|
33
ProQR Therapeutics
PRQR
$252M
| $7.07M | 0.65% |
448,141
-3,291,265
| -88% | -$51.9M |
|
|
CHAC.U
34
DELISTED
Chardan Healthcare Acquisition Corp.
CHAC.U
| $6.04M | 0.55% |
+600,000
| New | +$6.04M |
|
|
VIVE
35
DELISTED
VIVEVE MED INC
VIVE
| $4.71M | 0.43% |
4,481
+1,334
| +42% | +$1.4M |
|
|
ODT
36
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $4.39M | 0.4% |
311,790
+22,182
| +8% | +$312K |
|
37
Solid Biosciences
SLDB
$433M
| $3.58M | 0.33% |
8,900
-8,588
| -49% | -$3.45M |
|
38
Neuronetics
STIM
$219M
| $3.25M | 0.3% |
167,728
+10,241
| +7% | +$198K |
|
39
electroCore
ECOR
$37.3M
| $3.24M | 0.3% |
34,569
+257
| +0.7% | +$24.1K |
|
40
argenx
ARGX
$44.9B
| $2.77M | 0.25% |
28,777
+1,924
| +7% | +$185K |
|
|
LJPC
41
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.53M | 0.23% |
268,036
-929,071
| -78% | -$8.76M |
|
|
MRTX
42
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.64M | 0.15% |
+38,765
| New | +$1.64M |
|
|
MOTS
43
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $1.43M | 0.13% |
1,532
+1,334
| +674% | +$1.24M |
|
|
KA
44
DELISTED
Kineta, Inc. Common Stock
KA
| $1.02M | 0.09% |
2,239
-5,826
| -72% | -$2.64M |
|
|
OPTN
45
DELISTED
OptiNose
OPTN
| $493K | 0.05% |
+5,298
| New | +$493K |
|
46
Catheter Precision
VTAK
$3.12M
| – | – |
0
| – | -$2M |
|
47
Eledon Pharmaceuticals
ELDN
$156M
| – | – |
-17,570
| Closed | -$1.48M |
|
|
48
Illumina
ILMN
$15.5B
| – | – |
-84,934
| Closed | -$30.3M |
|
49
Marker Therapeutics
MRKR
$11.1M
| – | – |
-20,972
| Closed | -$1.9M |
|
50
Novavax
NVAX
$1.27B
| – | – |
-138,551
| Closed | -$5.21M |
|